Your browser doesn't support javascript.
Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey.
Kantarcioglu, Bulent; Patel, Krishan; Lewis, Joseph; Iqbal, Omer; Siddiqui, Fakiha; Jabeen, Nusrat; Laddu, Atul R; Carter, Charles A; Fareed, Jawed.
  • Kantarcioglu B; 2456Loyola University Chicago, Maywood, IL, USA.
  • Patel K; Global Thrombosis Forum (GTF), Suwanee, GA, USA.
  • Lewis J; 2456Loyola University Chicago, Maywood, IL, USA.
  • Iqbal O; 2456Loyola University Chicago, Maywood, IL, USA.
  • Siddiqui F; 2456Loyola University Chicago, Maywood, IL, USA.
  • Jabeen N; University of Karachi, Karachi, Pakistan.
  • Laddu AR; Global Thrombosis Forum (GTF), Suwanee, GA, USA.
  • Carter CA; Campbell University College of Pharmacy and Health, Sciences, 2078Campbell University, Buies Creek, NC, USA.
  • Fareed J; 2456Loyola University Chicago, Maywood, IL, USA.
Clin Appl Thromb Hemost ; 27: 10760296211066942, 2021.
Article in English | MEDLINE | ID: covidwho-1574701
ABSTRACT

INTRODUCTION:

We conducted a cross-sectional survey as a part of an educational program in collaboration with the Global Thrombosis Forum (GTF), an affiliate of North American Thrombosis Forum (NATF), and Loyola University about public perceptions of COVID-19 and COVID-19 vaccinations in the US. In this study, we are reporting the results of this survey. MATERIALS AND

METHODS:

The survey, in the form of a questionnaire, has been developed by GTF and faculty members. A prepared questionnaire was sent to the members of the Georgia and Illinois communities.

RESULTS:

In our current study, the COVID-19 vaccine willingness rate was 94.5% and vaccination rate was 90.9%. In multivariate analysis believing to have enough information about the safety and efficacy of COVID-19 vaccines (OR 3.730, 95% CI 1.199-11.603, p 0.023) and gender (OR 0.123, 95% CI 0.016-0.967, p 0.046) were significant predictors for vaccine willingness. Previous COVID-19 infection (OR 0.215, 95% CI 0.061-0.758, p 0.017), moderate and severe effects of COVID-19 pandemic on participant's life (OR 4.631, 95% CI 1.681-12.760, p 0.003) and believing to have enough information about the safety and efficacy of COVID-19 vaccines (OR 4.119, 95% CI 1.508-11.253, p 0.006) were significant predictors for final vaccination status.

CONCLUSION:

In conclusion, currently vaccination remains one of the most effective tools in the fight against the COVID-19 pandemic. The vaccine hesitancy is a complex phenomenon that is driven by individuals' perceptions of safety, and efficiency of the vaccines. We must continue to educate the public and communities that vaccines are safe, that they are effective and that they are still required even after a COVID-19 infection.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / COVID-19 Vaccines / SARS-CoV-2 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Female / Humans / Male / Young adult Language: English Journal: Clin Appl Thromb Hemost Journal subject: Vascular Diseases Year: 2021 Document Type: Article Affiliation country: 10760296211066942

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / COVID-19 Vaccines / SARS-CoV-2 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Female / Humans / Male / Young adult Language: English Journal: Clin Appl Thromb Hemost Journal subject: Vascular Diseases Year: 2021 Document Type: Article Affiliation country: 10760296211066942